WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience ScienceCareers.org
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
The Journal of Neuroscience, June 20, 2007, 27(25):6823-6831; doi:10.1523/JNEUROSCI.0013-07.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mark, K. A.
Right arrow Articles by Yamamoto, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mark, K. A.
Right arrow Articles by Yamamoto, B. K.

 Previous Article  |  Next Article 

Neurobiology of Disease
Dynamic Changes in Vesicular Glutamate Transporter 1 Function and Expression Related to Methamphetamine-Induced Glutamate Release

Karla A. Mark,1 Maria S. Quinton,1 Shelley J. Russek,2 and Bryan K. Yamamoto1

Laboratories of 1Neurochemistry and 2Molecular Neurobiology, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118

Correspondence should be addressed to Bryan K. Yamamoto, Department of Pharmacology, Boston University School of Medicine, 715 Albany Street, L-613, Boston, MA 02118. Email: bkyam{at}bu.edu

The vesicular glutamate (GLU) transporter (VGLUT1) is a critical component of glutamatergic neurons that regulates GLU release. Despite the likely role of GLU release in drug abuse pathology, there is no information that links VGLUT1 with drugs of abuse. This study provides the first evidence that methamphetamine (METH) alters the dynamic regulation of striatal VGLUT1 function and expression through a polysynaptic pathway. METH increases cortical VGLUT1 mRNA, striatal VGLUT1 protein in subcellular fractions, and the Vmax of striatal vesicular GLU uptake. METH also increases glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein in the crude vesicle fraction. METH-induced increases in cortical VGLUT1 mRNA, as well as striatal VGLUT1 and GAPDH, are GABAA receptor-dependent because they are blocked by GABAA receptor antagonism in the substantia nigra. These results show that VGLUT1 can be dynamically regulated via a polysynaptic pathway to facilitate vesicular accumulation of GLU for subsequent release after METH.

Key words: methamphetamine; VGLUT1; basal ganglia; striatum; substantia nigra; glutamate

Received Jan. 3, 2007; revised April 18, 2007; accepted May 11, 2007.

Correspondence should be addressed to Bryan K. Yamamoto, Department of Pharmacology, Boston University School of Medicine, 715 Albany Street, L-613, Boston, MA 02118. Email: bkyam{at}bu.edu






-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-